Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/08/2023 | Revolution Medicines, Inc. | RVMD | Grant | Common Stock | 5.2k | $0.00 | $0 | | 06/08/2023 |
06/08/2023 | Revolution Medicines, Inc. | RVMD | Grant | Stock Option (Right to Buy) | 18.4k | $24.84 | $457.1k | | 06/08/2023 |
05/25/2023 | RELMADA THERAPEUTICS, INC. | RLMD | Grant | Stock Option (right to buy) | 93k | $3.37 | $313.3k | | 05/25/2023 |
03/22/2023 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 558.1k | $0.00 | $0 | | 03/22/2023 |
03/22/2023 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 432.7k | $5.04 | $2.2M | | 03/22/2023 |
03/14/2023 | Allogene Therapeutics, Inc. | ALLO | Payment of Exercise | Common Stock | 35.9k | $5.47 | $196.3k | | 03/14/2023 |
12/16/2022 | RELMADA THERAPEUTICS, INC. | RLMD | Grant | Stock Option (right to buy) | 57k | $3.37 | $192.2k | | 12/16/2022 |
06/16/2022 | Revolution Medicines, Inc. | RVMD | Grant | Common Stock | 5.2k | $0.00 | $0 | | 06/16/2022 |
06/16/2022 | Revolution Medicines, Inc. | RVMD | Grant | Stock Option (Right to Buy) | 18.4k | $16.80 | $309.1k | | 06/16/2022 |
05/25/2022 | RELMADA THERAPEUTICS, INC. | RLMD | Grant | Stock Option (right to buy) | 91.2k | $19.03 | $1.7M | | 12/17/2021 |
03/23/2022 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 237.4k | $0.00 | $0 | | 03/23/2022 |
03/23/2022 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 368.6k | $9.69 | $3.6M | | 03/23/2022 |
03/15/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 11.5k | $7.63 | $87.6k | | 03/15/2022 |
12/17/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Grant | Stock Option (right to buy) | 58.8k | $19.03 | $1.1M | | 12/17/2021 |
06/22/2021 | Revolution Medicines, Inc. | RVMD | Grant | Common Stock | 3.6k | $0.00 | $0 | | 06/22/2021 |
06/22/2021 | Revolution Medicines, Inc. | RVMD | Grant | Stock Option (Right to Buy) | 12.7k | $32.93 | $416.9k | | 06/22/2021 |
05/24/2021 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 14.9k | $18.22 | $271.4k | | 05/24/2021 |
03/26/2021 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 24.9k | $0.00 | $0 | | 03/26/2021 |
03/26/2021 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 92.4k | $33.78 | $3.1M | | 03/26/2021 |
03/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 8.1k | $38.23 | $307.9k | | 03/15/2021 |
01/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 400 | $33.29 | $13.3k | See footnote | 01/14/2021 |
01/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 11.1k | $32.40 | $358.2k | See footnote | 01/14/2021 |
01/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 3.5k | $31.69 | $112.4k | See footnote | 01/14/2021 |
01/14/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5.1k | $31.10 | $160.1k | See footnote | 01/14/2021 |
01/14/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 9.9k | $30.60 | $301.5k | See footnote | 01/14/2021 |
01/07/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Grant | Options to purchase common stock | 100k | $33.43 | $3.3M | | 01/07/2021 |
11/16/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 4.6k | $32.60 | $151.1k | See footnote | 11/16/2020 |
11/16/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 10.4k | $33.00 | $342.1k | See footnote | 11/16/2020 |
10/15/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5.1k | $39.47 | $201.4k | See footnote | 10/15/2020 |
10/15/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 4.2k | $40.07 | $169k | See footnote | 10/15/2020 |
10/15/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 3.5k | $41.33 | $143.8k | See footnote | 10/15/2020 |
10/15/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 2.1k | $42.32 | $88.8k | See footnote | 10/15/2020 |
10/15/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 100 | $43.01 | $4.3k | See footnote | 10/15/2020 |
09/21/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 9.9k | $34.76 | $343.7k | See footnote | 09/21/2020 |
09/21/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 1.9k | $37.04 | $70.8k | See footnote | 09/21/2020 |
|